Holen Sie sich die Stockscreener-App
2.47
2.92%
-0.10
Schlusskurs vom Vortag:
$2.57
Offen:
$2.55
24-Stunden-Volumen:
60,467
Relative Volume:
0.27
Marktkapitalisierung:
$30.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.54%
1M Leistung:
+20.53%
6M Leistung:
+52.13%
1J Leistung:
-94.67%
1-Tages-Spanne:
$2.47
$2.71
1-Wochen-Bereich:
$2.47
$2.91
52-Wochen-Spanne:
$1.345
$51.26
Q 32 Bio Inc Stock (QTTB) Company Profile
Firmenname
Q 32 Bio Inc
Sektor
Branche
Telefon
781-999-0232
Adresse
830 WINTER STREET, WALTHAM
Vergleichen Sie QTTB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
2.495 | 31.35M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.19 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
630.06 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.86 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
841.28 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.87 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-11 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-12-11 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-24 | Eingeleitet | Raymond James | Strong Buy |
| 2024-09-11 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-17 | Eingeleitet | Guggenheim | Buy |
| 2024-05-21 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-02 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | Bestätigt | BTIG Research | Neutral |
| 2022-02-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-02-22 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-12-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-03-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-02-24 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-11-01 | Eingeleitet | Oppenheimer | Perform |
| 2019-09-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-04-12 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Q 32 Bio Inc Aktie (QTTB) Neueste Nachrichten
Intraday pattern recognizer results for Q32 Bio Inc.Weekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Why Q32 Bio Inc. stock is a must watch in 2025July 2025 Action & Weekly Return Optimization Alerts - newser.com
Is Q32 Bio Inc. stock reversal real or fake2025 Buyback Activity & Daily Profit Maximizing Trade Tips - newser.com
Q32 Bio Inc expected to post a loss of $1.19 a shareEarnings Preview - TradingView
Price momentum metrics for Q32 Bio Inc. explainedEarnings Summary Report & Stepwise Trade Signal Implementation - newser.com
Can Q32 Bio Inc. rally from current levelsJuly 2025 Volume & Trade Opportunity Analysis - newser.com
Sentiment analysis tools applied to Q32 Bio Inc.Weekly Loss Report & Verified Momentum Stock Ideas - newser.com
Tick level data insight on Q32 Bio Inc. volatilityJuly 2025 Update & Accurate Technical Buy Alerts - newser.com
How Q32 Bio Inc. stock reacts to oil pricesShare Buyback & Low Drawdown Momentum Ideas - newser.com
Trend analysis for Q32 Bio Inc. this weekSell Signal & AI Enhanced Trade Execution Alerts - newser.com
Q32 Bio Inc. stock trendline breakdownProduct Launch & Real-Time Chart Pattern Alerts - newser.com
Is Q32 Bio Inc. stock cheap compared to fundamentalsJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - newser.com
Key resistance and support levels for Q32 Bio Inc.July 2025 Levels & Proven Capital Preservation Tips - newser.com
What analysts say about Q32 Bio Inc stockMid Cap Growth Trends & Free High Yield Portfolio Picks - earlytimes.in
Why analysts upgrade Q32 Bio Inc. stockJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - fcp.pa.gov.br
Finanzdaten der Q 32 Bio Inc-Aktie (QTTB)
Es liegen keine Finanzdaten für Q 32 Bio Inc (QTTB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Q 32 Bio Inc-Aktie (QTTB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Violette Shelia M. | Chief Scientific Officer |
Aug 26 '25 |
Sale |
1.80 |
2,990 |
5,385 |
58,384 |
| Kalowski Lee | CFO and President |
Aug 26 '25 |
Sale |
1.80 |
4,240 |
7,636 |
49,010 |
1.14%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):